AbbVie Inc. (ABBV)
AbbVie Inc. reported revenue of $61.16B for the fiscal year ended Dec 31, 2025, up 8.6% from $56.33B the year before. Net income was $4.23B, a net margin of 6.9% (prior year: $4.28B). At the end of that fiscal year the company reported total assets of $133.96B and shareholders' equity of −$3.27B.
Revenue
$61.16B
+8.6% vs prior year
Net income
$4.23B
Net margin 6.9%
Diluted EPS
$2.36
USD per share
Total assets
$133.96B
At Dec 31, 2025
Equity
−$3.27B
At Dec 31, 2025
Shares outstanding
1,768M
As of Oct 26, 2026
Explore AbbVie Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Nov 3, 2026
- 10-QFiled Aug 3, 2026
- 10-QFiled May 8, 2026
- 10-KFiled Feb 20, 2026
- 10-QFiled Nov 4, 2025
- 10-QFiled Aug 4, 2025
Compare AbbVie Inc.
- BMYABBV vs BMY
Source: SEC EDGAR XBRL company facts for CIK 1551152 (raw data). Most recent filing in this dataset: 10-Q filed Nov 3, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.